Barclays’s Antares Pharma, Inc. ATRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-97,509
Closed -$399K 5131
2022
Q1
$399K Sell
97,509
-185,823
-66% -$760K ﹤0.01% 2936
2021
Q4
$1.01M Buy
283,332
+117,863
+71% +$421K ﹤0.01% 2200
2021
Q3
$602K Buy
165,469
+143,738
+661% +$523K ﹤0.01% 2520
2021
Q2
$96K Sell
21,731
-166,206
-88% -$734K ﹤0.01% 3151
2021
Q1
$772K Buy
187,937
+125,078
+199% +$514K ﹤0.01% 2433
2020
Q4
$251K Sell
62,859
-22,361
-26% -$89.3K ﹤0.01% 2611
2020
Q3
$230K Sell
85,220
-14,994
-15% -$40.5K ﹤0.01% 2667
2020
Q2
$275K Buy
100,214
+36,707
+58% +$101K ﹤0.01% 2646
2020
Q1
$150K Sell
63,507
-127,479
-67% -$301K ﹤0.01% 2664
2019
Q4
$897K Buy
190,986
+90,830
+91% +$427K ﹤0.01% 2363
2019
Q3
$335K Sell
100,156
-24,115
-19% -$80.7K ﹤0.01% 2823
2019
Q2
$409K Buy
124,271
+17,137
+16% +$56.4K ﹤0.01% 2833
2019
Q1
$325K Buy
107,134
+73,970
+223% +$224K ﹤0.01% 2815
2018
Q4
$90K Sell
33,164
-55,774
-63% -$151K ﹤0.01% 3006
2018
Q3
$299K Buy
88,938
+58,366
+191% +$196K ﹤0.01% 2877
2018
Q2
$80K Sell
30,572
-19,403
-39% -$50.8K ﹤0.01% 3149
2018
Q1
$109K Buy
49,975
+3,224
+7% +$7.03K ﹤0.01% 3133
2017
Q4
$93K Sell
46,751
-89,587
-66% -$178K ﹤0.01% 3045
2017
Q3
$442K Buy
136,338
+105,644
+344% +$342K ﹤0.01% 1985
2017
Q2
$98K Buy
30,694
+2,030
+7% +$6.48K ﹤0.01% 2778
2017
Q1
$82K Buy
28,664
+18,864
+192% +$54K ﹤0.01% 2922
2016
Q4
$23K Buy
+9,800
New +$23K ﹤0.01% 3054
2016
Q3
Sell
-18,125
Closed -$19K 4124
2016
Q2
$19K Buy
+18,125
New +$19K ﹤0.01% 2831
2015
Q4
Sell
-809
Closed -$1K 3906
2015
Q3
$1K Sell
809
-2,162
-73% -$2.67K ﹤0.01% 3807
2015
Q2
$6K Sell
2,971
-31,338
-91% -$63.3K ﹤0.01% 3548
2015
Q1
$69K Buy
34,309
+27,660
+416% +$55.6K ﹤0.01% 2628
2014
Q4
$13K Buy
6,649
+2,608
+65% +$5.1K ﹤0.01% 3632
2014
Q3
$4K Buy
4,041
+1,959
+94% +$1.94K ﹤0.01% 4026
2014
Q2
$4K Sell
2,082
-2,527
-55% -$4.86K ﹤0.01% 3976
2014
Q1
$14K Sell
4,609
-1,677
-27% -$5.09K ﹤0.01% 3686
2013
Q4
$25K Buy
6,286
+2,061
+49% +$8.2K ﹤0.01% 3651
2013
Q3
$17K Sell
4,225
-1,606
-28% -$6.46K ﹤0.01% 3529
2013
Q2
$24K Buy
+5,831
New +$24K ﹤0.01% 3625